Real-World Insights

Using Real World Clinical NGS Data for Precision Oncology

March 15, 2021
Next generation sequencing (NGS) has become a routine component in oncology diagnostics. As a result NGS data volumes are growing exponentially. Through its clinical decision support software and services, QIAGEN is uniquely positioned to integrate and analyze this data in the context of other data to help guide drug development and clinical trials. Through illustration of industry relevant use cases this webinar will explore the utility of QIAGEN’s large and diverse molecular database and its value for decision making across the drug development lifecycle.

Related videos

Real-World Insights

Fireside Chat with Debiopharm: Using real-world genomic data to support drug and biomarker...

321 views June 16, 2020

During this interactive webcast, the QIAGEN Real-World Insights team will...

Real-World Insights

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

219 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...